InvestorsHub Logo
icon url

ronpopeil

06/24/11 1:01 PM

#3097 RE: Artale #3095

I agree. Also, people are still not talking about LaViv's application to acne scarring, burns, vocal cord scarring etc. These are all huge, unique markets. Getting approval "de-risks" this stock. I think a bigger, competing company may have some interest. They could easily buy FCSC for very little (little for them) and have the market cornered on wrinkles, acne scars etc.
icon url

picheljitsu

06/24/11 1:20 PM

#3104 RE: Artale #3095

My mind is a little fuzzy. Have they completely opted out of partnering, or are they considering seeing that they're not in the best financial shape?